Adamas Pharmaceuticals, Inc. Free Cash Flow 2014-2021 | ADMS
Adamas Pharmaceuticals, Inc. free cash flow from 2014 to 2021. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Adamas Pharmaceuticals, Inc. Annual Free Cash Flow |
2020 |
-50.71 |
2019 |
-80.80 |
2018 |
-105.29 |
2017 |
-68.09 |
2016 |
-49.69 |
2015 |
-48.61 |
2014 |
26.51 |
2013 |
26.63 |
2012 |
51.94 |
Adamas Pharmaceuticals, Inc. Quarterly Free Cash Flow |
2021-09-30 |
-36.52 |
2021-06-30 |
-30.27 |
2021-03-31 |
-21.06 |
2020-12-31 |
-50.71 |
2020-09-30 |
-40.38 |
2020-06-30 |
-29.53 |
2020-03-31 |
-17.31 |
2019-12-31 |
-80.80 |
2019-09-30 |
-62.48 |
2019-06-30 |
-43.83 |
2019-03-31 |
-20.92 |
2018-12-31 |
-105.29 |
2018-09-30 |
-82.30 |
2018-06-30 |
-57.88 |
2018-03-31 |
-25.30 |
2017-12-31 |
-68.09 |
2017-09-30 |
-42.94 |
2017-06-30 |
-27.24 |
2017-03-31 |
-14.30 |
2016-12-31 |
-49.69 |
2016-09-30 |
-39.66 |
2016-06-30 |
-25.76 |
2016-03-31 |
-12.96 |
2015-12-31 |
-48.61 |
2015-09-30 |
-36.00 |
2015-06-30 |
-24.49 |
2015-03-31 |
-14.08 |
2014-12-31 |
26.51 |
2014-09-30 |
7.05 |
2014-06-30 |
13.97 |
2014-03-31 |
-6.86 |
2013-12-31 |
26.63 |
2013-09-30 |
-9.93 |
2013-06-30 |
-4.72 |
2013-03-31 |
-2.98 |